CombiMatrix Company

CombiMatrix develops proprietary technologies, products and services for drug development, genetic analysis, molecular diagnostics and more. CombiMatrix Corporation develops proprietary technologies, products, and services in the areas of drug development, genetic analysis, molecular diagnostics, nanotechnology, and defense and homeland security. Its technologies include a platform to produce user-defined, in-situ synthesized, and oligonucleotide arrays for use in identifying and determining the roles of genes, gene mutations, and proteins. The company’s products and services include CustomArray platform, an oligonucleotide array for genetic studies; DNA Array Synthesizer, an instrument that enables researchers to fabricate DNA arrays to their specifications; stripping reagents, which enable researchers to re-use microarrays; ElectraSense Reader, an electrochemical scanning instrument; and comparative genomic hybridization arrays, which are used for research and molecular diagnostic applications.
Technology: Preventive Diagnostics
Industry: Precision Medicine
Headquarters: Irvine
Founded Date: 1995
Employees Number: 51-100
Funding Status: M&A

Visit Website
clientservices@cmdiagnostics.com
https://www.twitter.com/combimatrix
Register and Claim Ownership